SIETES :: 93213 citas

Resultados de la búsqueda por PALIPERIDONA REFINAR BÚSQUEDA

1.

Anónimo. ‘Sí’ de la UE a un antipsicótico de Janssen de acción larga. Correo Farmacéutico 2016:17. [Ref.ID 100408]

2.

Anónimo. QT interval and drug therapy. Drug Ther Bull 2016;54:33-6. [Ref.ID 100134]

3.

Anónimo. ‘Sí’ de la EMA a palmitato de paliperidona, de Janssen, en presentación trimestral. Correo Farmacéutico 2016:17. [Ref.ID 100109]

4.

Anónimo. Two long-acting injectable antipsychotics for schizophrenia. The Medical Letter on Drug and Therapeutics Bulletin 2015;57:152-3. [Ref.ID 99815]

5.

Takeuchi Y. Atypical antipsychotics and the risk of hyperlipidemia: A sequence symmetry analysis. Drug Saf 2015;38:641-50. [Ref.ID 99240]

6.

Ibañez C, Zara C. Observatori de consum de medicaments. Prescripció off-label d'antipsicòtics a l'RSB. e-farma RSB 2015;23:8-9. [Ref.ID 99062]

7.

Borrell M, Clusa Gironella D. Una proposta per a la prescripció racional de neurolèptics. e-farma RSB 2015;23:5-7. [Ref.ID 99057]

8.

McEvoy JP, Byerly M, Hamer RM, Dominik R, Swartz MS, Rosenheck RA, Ray N, Lamberti JS, Buckley PF, Wilkins TM, Stroup TS. Effectiveness of paliperidone vs haloperidol decanoate for maintenance treatment of schizophrenia: a randomized clinical trial. JAMA 2014;311:1978-87. [Ref.ID 97624]

9.

Goff DC. Maintenance treatment with long-acting injectable antipsychotics: comparing old with new. JAMA 2014;311:1973-4. [Ref.ID 97623]

10.

Anónimo. Neuroleptiques "atypiques": troubles compulsifs. Prescrire 2013;33:673-4. [Ref.ID 96189]

11.

Leucht S, Cipriani A, Spineli L, Mavridis D, Örey D, Richter F, Samara M, Barbui C, Engel RR, Geddes JR, Kissling W, Stapf MP, Lässig B, Salanti G, Davis JM. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet 2013;382:951-62. [Ref.ID 96106]

12.

Correli CU, De Hert M. Antipsychotics for acute schizophrenia: making choices. Lancet 2013;382:919-20. [Ref.ID 96104]

13.

14.

Kesselheim AS. Drug company gifts to medical students: the hidden curriculum. BMJ 2013;346:8. [Ref.ID 94974]

15.

Kuehn BM. Off-label atypical antipsychotics. JAMA 2012;308:1198. [Ref.ID 93799]

16.

Anónimo. Second generation long-acting injectable antipsychotic agents: an overview. Drug Ther Bull 2012;50:102-5. [Ref.ID 93654]

17.

Miselli M. Paliperidone palmitato. Informazioni sui Farmaci 2012;36:54-5. [Ref.ID 93314]

18.

Anónimo. Palipéridone injectable à libération prolongée. Sans progrès pour le traitement à long terme de la schizophrénie. Prescrire 2012;32:411. [Ref.ID 93114]

19.

Anónimo. Antipsychotics in children and adolescents: cardiometabolic reactions. Canada. WHO Drug Information 2012;26:29-30. [Ref.ID 92558]

20.

Anónimo. Monitoring unwanted effects of antipsychotics. Drug Ther Bull 2011;49:117-20. [Ref.ID 91992]